Clinical Trial

Spyral InSight Study

Study acronym: Spyral InSight
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Spyral InSight Early Clinical Feasibility Study is to characterize the physiological response to renal nerve stimulation (RNS) in humans prior to and post renal denervation.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-02; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT07013929
Lead Sponsor Medtronic Vascular
Conditions Hypertension, Vascular Diseases, Cardiovascular Diseases
Enrollment 19 participants
Start Date 2025-06-09
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04